Pulmonx Corporation
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
/ 
Frequently asked questions
To buy Pulmonx Corporation stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Pulmonx Corporation by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Pulmonx Corporation is LUNG:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Pulmonx Corporation has its primary listing on NASDAQ. You can trade Pulmonx Corporation with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Pulmonx Corporation is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Pulmonx Corporation as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Pulmonx Corporation.